Le Lézard
Classified in: Health
Subjects: MAV, EXE, FVT

Media Advisory - Minister Petitpas Taylor visits arthritis researchers at the Université de Moncton on World Arthritis Day


MONCTON, NB, Oct. 11, 2017 /CNW/ - The Honourable Ginette Petitpas Taylor, Minister of Health, will visit the Université de Moncton to meet researchers working on arthritis for World Arthritis Day. She will also have the opportunity to meet researchers working on other diverse topics including cancer and metabolism.

 

Date:

October 12, 2017



Time:

9:30 a.m. 



Location:

Université de Moncton


Pavillon Rémi-Rossignol


60, rue Notre-Dame-du-Sacré-Coeur


Moncton, NB E1A 3E9 Canada

 

Media are invited to speak with the Minister and researchers, participate in a lab tour, and take photos and video.            

           

SOURCE Canadian Institutes of Health Research


These press releases may also interest you

at 13:26
In a bid to foster excellence and innovation in the healthcare industry, the esteemed Dr. Vidal Sheen proudly announces the launch of The Dr. Vidal Sheen Grant for Healthcare Students. With a robust focus on academic prowess, compassionate care, and...

at 13:17
Rexall is proud to unveil its first Pharmacist Care Walk-In Clinic in Barrie, Ontario on Friday, April 19. Located at 353 Duckworth Street, the clinic will offer personalized care to the community while providing immediate pharmacist treatment for...

at 13:13
Caring for communities extends beyond life-changing work in operating rooms and physician offices. Hartford HealthCare leadership today highlighted its corporate responsibility to environmental, social and economic sustainability in announcing its...

at 13:04
Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" using MagicTouch ? Sirolimus drug coated balloon (DCB), for the management of in-stent...

at 12:30
The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes. The clinical guideline is based on the best...

at 12:10
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...



News published on and distributed by: